Q32 Bio (QTTB) Enterprise Value (2017 - 2026)

Q32 Bio's Enterprise Value history runs 10 years deep, the most recent figure standing at -$50.8 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 22.5% year-over-year to -$50.8 million; the TTM figure through Mar 2026 stood at -$50.8 million (up 22.5% YoY), while the FY2025 annual figure was -$48.3 million, up 38.05% from the prior year.
• Enterprise Value was -$50.8 million for Q1 2026 at Q32 Bio, down from -$48.3 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$25.6 million in Q4 2023 to a low of -$256.1 million in Q1 2022.
• Historically, Enterprise Value has averaged -$112.0 million across 5 years, with a median of -$89.1 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Enterprise Value jumped 85.36% in 2023, then sank 204.35% in 2024.
• A 5-year view of Enterprise Value shows it stood at -$175.0 million in 2022, then surged by 85.36% to -$25.6 million in 2023, then tumbled by 204.35% to -$78.0 million in 2024, then soared by 38.05% to -$48.3 million in 2025, then retreated by 5.08% to -$50.8 million in 2026.
• The last three Enterprise Value figures came in at -$50.8 million (Q1 2026), -$48.3 million (Q4 2025), and -$68.9 million (Q3 2025), per Business Quant data.